Teradyne’s fair value estimate has been lifted from US$307.41 to US$369.53, pointing to a meaningfully higher modeled equity value in recent updates. This reset comes alongside a wave of Street research where many firms have raised price targets and some have issued upgrades, while others have turned cautious on how much optimism is already reflected in the stock. As you read on, you will see how to interpret these shifting targets and use the evolving analyst narrative to frame your own...